Proprietary Device Ecosystems vs. Open Reporting Platforms: How Locked-In Labs Compare to Manufacturer-Agnostic Solutions

Feb 20, 2026

Respiratory and sleep labs face a critical infrastructure decision that shapes their clinical workflows for years: build around a single device manufacturer's ecosystem, or adopt an open, manufacturer-agnostic reporting platform. The difference is not just technical. It determines how freely a lab can evolve, which devices it can use, and how much control it retains over its own data. Manufacturer-agnostic platforms give labs the freedom to choose the best equipment for their patients without forcing their reporting software to follow. Proprietary ecosystems, by contrast, often tie clinical decisions to commercial relationships.

TL;DR

  • Proprietary device ecosystems create vendor lock-in that limits equipment choice, increases costs, and can compromise clinical independence.

  • Open, manufacturer-agnostic platforms allow labs to integrate data from any device, reducing risk and improving flexibility.

  • Open-source and open-ecosystem software is increasingly competitive with proprietary solutions in quality and capability.

  • Switching from a locked-in system to an open platform is simpler than most labs expect.

  • Rezibase is a cloud-based, manufacturer-agnostic respiratory and sleep lab management software platform built by respiratory scientists, trusted across Australia and the NHS in the UK.

What Is Vendor Lock-In and Why Does It Matter in Respiratory Labs?

Vendor lock-in occurs when a lab becomes so dependent on a single manufacturer's software, data formats, or hardware that switching becomes prohibitively difficult or expensive. In respiratory and sleep labs, this typically happens when a spirometry or polysomnography device manufacturer bundles proprietary reporting software with their equipment, creating a closed loop where data only flows cleanly within their own ecosystem.

The practical consequences are significant:

  • Labs are pressured to repurchase from the same manufacturer when upgrading devices, regardless of clinical preference.

  • Patient data may be stored in proprietary formats that are difficult to export or migrate.

  • Integration with hospital systems such as EMRs or Patient Administration Systems becomes complex and costly.

  • When a manufacturer discontinues a product line or exits a niche market, the lab's software investment can become stranded. As noted by the MERL Center, "In niche markets, proprietary solutions can disappear with small companies," leaving labs exposed.

How Do Proprietary Ecosystems Gain and Maintain Their Hold?

Proprietary platforms are not inherently bad. According to Martech Outlook, proprietary ecosystem platforms offer tightly integrated experiences and centralised management that can reduce friction in specific contexts. The problem arises when that integration becomes a mechanism for commercial control rather than clinical benefit.

Device manufacturers use several strategies to entrench their ecosystems:

Strategy

How It Creates Lock-In

Proprietary data formats

Data cannot be easily read by third-party software

Bundled software licensing

Reporting tools are tied to hardware purchases

Closed APIs

External systems cannot integrate without manufacturer approval

Siloed normal values libraries

Labs must use manufacturer-defined reference ranges

As Memoori's analysis of open standards versus closed ecosystems highlights, the battle between open and closed approaches "will continue to strangle market growth" until industries shift toward interoperability. Respiratory diagnostics is not immune to this dynamic.

What Are the Real Risks of Staying in a Closed Ecosystem?

Beyond commercial inconvenience, proprietary lock-in carries genuine clinical and operational risks:

  • Data integrity risk: Double data entry between device software and hospital systems increases the chance of transcription errors, a direct patient safety concern.

  • Compliance risk: Closed systems may not update quickly enough to reflect evolving ATS guidelines or accreditation standards like TSANZ/NATA and ISO 15189.

  • Scalability risk: As labs grow or merge, proprietary systems often cannot accommodate multi-site or multi-device environments without expensive custom work.

  • Continuity risk: Nextcloud's research into open versus proprietary software notes that organisations using closed platforms risk losing control over their data entirely if a vendor changes terms or exits the market.

Why Is the Open Platform Model Gaining Ground?

According to Planet Crust's 2025 analysis, open-source and open-ecosystem software "is beginning to assert its dominance" over proprietary alternatives, driven by greater flexibility, improving quality, and a wider range of choices available to organisations. This shift is visible in healthcare technology, where labs are increasingly demanding systems that serve their clinical needs rather than a manufacturer's commercial interests.

Open platforms offer:

  • Device agnosticism: Import data from any spirometer, sleep study device, or diagnostic tool regardless of brand.

  • Interoperability: Clean integration with EMRs, DICOM worklists, hospital finance systems, and electronic ordering.

  • Portability: Patient data stored in accessible formats that the lab controls.

  • Future-proofing: The ability to adopt new devices or change suppliers without rebuilding reporting infrastructure.

Digiqt's analysis of open versus proprietary data platforms reinforces this, noting that open approaches reduce vendor dependency, control costs, and scale more effectively across complex environments.

What Should a Respiratory Lab Look for in a Manufacturer-Agnostic Platform?

Not all open platforms are equal. When evaluating sleep lab management software or a broader respiratory reporting solution, labs should assess the following:

  • Clinical workflow alignment: Was the platform designed by clinicians, or adapted from a generic software template?

  • Data import capability: Can it automatically extract discrete data, including flow-volume loops, from any device report without manual re-entry?

  • Normal values management: Does it maintain a regularly updated library aligned with current reference standards?

  • Accreditation support: Does it include tools for document management, quality control, non-conformance tracking, and audit management to meet ISO 15189 and TSANZ/NATA requirements?

  • Integration depth: Does it connect natively with hospital PAS, EMR, and finance systems?

  • Hosting flexibility: Is it cloud-based for accessibility, with enterprise on-premise options for hospitals with specific IT requirements?

Rezibase was designed by respiratory scientists Peter Rochford and the late Jeff Pretto specifically to answer these questions. The platform's Magic Import function automatically extracts discrete data from device reports across any manufacturer, eliminating double entry and the errors that come with it.

Is Switching from a Proprietary System to Rezibase Complicated?

This is the question most labs ask, and the honest answer is: less complicated than you might expect. The transition from a legacy or manufacturer-bundled system to Rezibase is designed to be straightforward. Historical patient data can be migrated, and the cloud-based delivery model means there is no server infrastructure to install or manage on site.

Platformable's research on open ecosystem design notes that understanding your role and positioning within a digital ecosystem is key to a successful transition. For respiratory labs, that means choosing a platform that integrates with existing hospital infrastructure rather than replacing it.

Rezibase connects with Patient Administration Systems, Electronic Medical Record systems, DICOM Modality Worklists, and hospital finance systems, meaning the transition is additive, not disruptive.

Frequently Asked Questions

Can Rezibase import data from any device manufacturer?
Yes. Rezibase's Magic Import function is designed to accept device reports from any spirometry or sleep study equipment, automatically extracting discrete data without manual re-entry.

Does Rezibase support accreditation requirements?
Yes. The platform includes a dedicated accreditation module covering TSANZ/NATA standards and ISO 15189, including document management, quality control, non-conformance tracking, and audit tools.

Is Rezibase only available in Australia?
No. Rezibase is used across Australia, New Zealand, the United Kingdom, and Ireland, including sites within the NHS.

What does the pricing model look like?
Rezibase operates on a transparent, all-inclusive monthly pricing model with no lock-in contracts and a 30-day free trial.

How long does implementation take?
Implementation timelines vary by site complexity, but Rezibase's cloud-based delivery and integration capabilities are designed to minimise disruption and accelerate onboarding.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, built by respiratory scientists for respiratory scientists. Trusted by over 35 sites including NHS and NSW Health, Rezibase delivers manufacturer-agnostic data import, AI-powered reporting, full accreditation support, and deep hospital system integration, all through a transparent monthly subscription with no lock-in contracts.

Explore how Rezibase can free your lab from proprietary constraints and simplify your reporting workflows. Visit rezibase.com to start your 30-day free trial or speak with the team.

References

Switching from ndd EasyOne Connect or Morgan Scientific: What Respiratory Scientists Wish They Knew Before Migrating to a Vendor-Neutral Platform ›

Switching from ndd EasyOne Connect or Morgan Scientific: What Respiratory Scientists Wish They Knew Before Migrating to a Vendor-Neutral Platform ›